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1. Introduction 
The poor yields and the high costs which charac- 
terize the purification of HLA antigens from cells 
(essentially from lymphoid cells in culture) led us to 
investigate another source for the transplantation 
antigens: the urine [1,2]. The present paper is dealing 
with the purification of urinary HLA antigens in order 
to obtain highly purified active molecules. 
(b) preparative polyacrylamide g l electrophoresis (a 
and b as described in [1]); (c) electrofocusing (LKB 
column, 110 ml capacity, carrier ampholines pH 4-6,  
180-500 V, 45 h) and (d) gel filtration on Sephadex 
G-25 (elimination of the ampholines). Analytical 
polyacrylamide g l electrophoresis of the purified 
active fractions was carried out in SDS containing 
systems [4]. Proteins were determined by the Folin 
procedure of Lowry et al. [5]. 
2. Materials and methods 
The urine was provided by a single donor (a patient 
suffering from cystinosis), whose HLA specificities 
had been phenotyped (HLA-A9, AW 33, B 12, B 14). 
The antigenic activity was monitored, at the different 
purification steps of the urine, by the complement 
fixation inhibition test [3]. 5 litre samples of urine 
(concentrated on Amicon DC-2 to 30-50 ml) were 
purified by (a) chromatography on DEAE-Sephadex; 
3. Results and discussion 
Table 1 points out the increase of specific activity 
(HLA-A9) during the different purificationsteps. A 
total 470-fold increase was obtained. Fig.1 represents 
the elution profil after electrofocusing and indicates 
the isoelectric points of HLA-A9 and B 12 antigens 
(5.1 and 4.7, respectively). But in spite of the high 
resolution power of this latter technique, the purified 
active fractions always contained 2 or 3 contaminants 
Table 1 
Proteins and activity (HLA-A9) during the purification of urinary HLA antigens 
Crude urine and Protein a Specific activity 
purification steps (mg) (I.U./mg protein) 
10 litre urine 4000 150 
DEAE-Sephadex A-50 660 1200 
Preparative polyacrylamide g l 
electrophoresis (Canalco apparatus) 60 3750 
Electrofocusing 
(LKB column; ampholines pH 4-6) 0.700 69 000 
a The protein content was determined on samples dialyzed on Diaflomembranes 
UM-20. 
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Fig. 1. Electrofocusing ofa 5 litre sample of urine (after ion exchange chromatography and preparative polyacrylamide g l electro- 
phoresis). 1.5 ml fractions. ( ) Absorbance at 280 nm; ( . . . . . . .  ) pH. Inhibition unit (I.U.): 1 I.U. = IDs0 = 50% inhibition 
dose. 
essentially albumin and a-globulins characterized by 
immunoelectrophoresis [6]. Analytical polyacryl- 
amide gel electrophoresis of the purified fractions 
showed 2 -3  proteins and glycoproteins with mol. wts. 
of about 60 000-80 000 and a glycoprotein with a 
mol. wt. of about 33 000. It was not possible to 
separate these molecules by gel fdtration on Sephadex 
G-150 in a 0.05 M Tris-HC1, 0.15 M NaC1 buffer pH 
7.4 because of the presence of relatively high amounts 
of albumin known for its strong interaction with 
other molecules. The separation could only been 
obtained in denaturing-conditions (6 M guanidine 
chloride) (fig.2). The characterization f the purified 
active HLA molecules was ascertained by the follow- 
ing two experiments: the active fractions provided by 
the purification of three 5 litre samples of urine were 
submitted to a second electrofocusing. Analytical 
polyacrylamide gel electrophoresis, n the presence of 
SDS, indicated an important increase of the 33 000 
dalton band, corresponding to the concomitant increase 
of the serological activity. The second indication that 
the HLA antigens in urine correspond to 33 000 dalton 
molecules was obtained by ultrafiltration (Amicon) 
on XM-50 membranes: the increase of the amount of 
33 000 dalton molecules in the ultrafiltrate went in 
parallel with the increase of HLA activity. 
No 152-microglobulin was present in the highly 
purified fractions. As already reported [2], most of 
the 152-microglobulin was lost during preparative 
polyacrylamide gel etectrophoresis. 
It should be emphasized that HLA antigens puri- 
fied from urine resemble those isolated from serum 
[7]. In both cases the transplantation a tigens howed 
mol. wts. similar to the molecules obtained by papain 
solubilization of cellular material [8], suggesting the 
rapid cleavage of a fragile peptide bond or/and a 
partial oss of carbohydrates. 
It is difficult to determine the yield of the HLA 
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Fig.2. Sodium dodecylsulfate-acrylamide gel scan analysis of 
about 50 ~g of the 33 000 dalton band obtained after gel 
filtration on Sephadex G-150, in 6 M guanidine-chloride. 
Amido black ( ) and periodate-Schiff ( . . . . . . . .  ) stained 
protein pattern. The abcissa gives the relative mobility, the 
ordinate the absorption for Amido black (620 nm) and 
periodate-Schiff reagent (560 nm). The arrows indicate the 
positions of the following marker proteins: bovine serum 
albumin (BSA), carboxypeptidase B (C), trypsine (T) and 
lysozyme (L). 
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number of purification steps. Thus our efforts are 
presently directed toward a simplification of the 
preparation procedure of the active primary material. 
Nevertheless the present results indicate that it was 
possible to obtain from pathological urines a 
highly purified HLA antigen. 
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